[1] Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet , 2008, 42: 301-334.
[2] O'Sullivan RJ, Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol , 2010, 11(3): 171-181.
[3] Kabir S, Hockemeyer D, de Lange T. TALEN gene knockouts reveal no requirement for the conserved human shelterin protein Rap1 in telomere protection and length regulation. Cell Rep , 2014, 9(4): 1273-1280.
[4] Aeby E, Lingner J. ALT telomeres get together with nuclear receptors. Cell , 2015, 160(5): 811-813.
[5] Ly H. Genetic and environmental factors influencing human diseases with telomere dysfunction. Clin Exp Med , 2009, 2(2): 114-130.
[6] Fu D, Collins K. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell , 2007, 28(5): 773-785.
[7] Venteicher AS, Meng ZJ, Mason PJ, Veenstra TD, Artandi SE. Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell , 2008, 132(6): 945-957.
[8] Zhong F, Savage SA, Shkreli M, Giri N, Jessop L, Myers T, Chen R, Alter BP, Artandi SE. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Gene Dev , 2011, 25(1): 11-16.
[9] Trochet D, Mergui X, Ivkovic I, Porreca RM, Gerbault-Seureau M, Sidibe A, Richard F, Londono-Vallejo A, Perret M, Aujard F, Riou JF. Telomere regulation during ageing and tumorigenesis of the grey mouse lemur. Biochimie , 2015, 113: 100-110.
[10] Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis , 2005, 26(5): 867-874.
[11] Killela PJ, Reitman ZJ, Jiao YC, Bettegowda C, Agrawal N, Diaz LA, Jr., Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He YP, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Ahmed Rasheed B, Riggins GJ, Rosenquist TA, Schiffman M, Shih IM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA , 2013, 110(15): 6021-6026.
[12] Horn S, Figl A, Sivaramakrishna Rachakonda P, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R. TERT promoter mutations in familial and sporadic melanoma. Science , 2013, 339(6122): 959-961.
[13] Kyo S, Takakura M, Fujiwara T, Inoue M. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci , 2008, 99(8): 1528-1538.
[14] Greenberg RA. Telomeres, crisis and cancer. Curr Mol Med , 2005, 5(2): 213-218.
[15] Borah S, Xi LH, Zaug AJ, Powell NM, Dancik GM, Cohen SB, Costello JC, Theodorescu D, Cech TR. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science , 2015, 347(6225): 1006-1010.
[16] Lacerte A, Korah J, Roy M, Yang XJ, Lemay S, Lebrun JJ. Transforming growth factor-β inhibits telomerase through SMAD3 and E2F transcription factors. Cell Signal , 2008, 20(1): 50-59.
[17] Ballal RD, Saha T, Fan SJ, Haddad BR, Rosen EM. BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. J Biol Chem , 2009, 284(52): 36083-36098.
[18] Zhu JY, Zhao YJ, Wang SW. Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein Cell , 2010, 1(1): 22-32.
[19] Wang SW, Hu CG, Zhu JY. Transcriptional silencing of a novel hTERT reporter locus during in vitro differentiation of mouse embryonic stem cells. Mol Biol Cell , 2007, 18(2): 669-677.
[20] Zhang ZX, Wang Y, Tao ZZ, Chen SM, Xiao BK, Zhou T. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma c
